Stryker Corporation (NYSE:SYK) traded negative at $114.44. On an intraday basis, the price dropped -0.12 points or -0.1%. The composite uptick value was $31.86 million while the combined downtick value was $24.4. The net money flow was $7.47 million while the up/down ratio was not very comforting at 1.31. The shares on a weekly note has seen a change in share price of 0.77%.According to the trading data, the shares saw a block trade with $9.31 million in upticks and $0 million in downticks. The up/down ratio for the block was calculated to be 0. The net money flow for the block trade was 9.31.
Currently the company Insiders own 7.8% of Stryker Corporation shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -57.96% . Institutional Investors own 76.62% of Stryker Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -29.78%. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director of Stryker Corp, Stryker Ronda E had sold 12,000 shares worth of $1,371,960 in a transaction dated June 8, 2016. In this transaction, 12,000 shares were sold at $114.33 per share.
Stryker Corporation (NYSE:SYK) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.12 points or 0.1% at $114.44 with 1,200,215 shares getting traded. Post opening the session at $114.56, the shares hit an intraday low of $114.36 and an intraday high of $115.54 and the price was in this range throughout the day. The company has a market cap of $42,798 million and the number of outstanding shares have been calculated to be 373,981,100 shares. The 52-week high of Stryker Corporation (NYSE:SYK) is $115.9 and the 52-week low is $86.68.
Many analysts have stated their opinion on the company shares. Guggenheim Securities initiates coverage on Stryker Corporation (NYSE:SYK).The analysts at the brokerage house have a current rating of Buy on the shares. The rating by the firm was issued on June 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.